Full Scale IQ (FSIQ) changes in children treated with whole brain and partial brain irradiation: A review and analysis;Full-Scale-IQ-(FSIQ-) veranderungen nach ganz- und teilhirnbestrahlung des kindlichen gehirns: Review und analyse

Strahlentherapie und Onkologie

Volumn 176, Issue 12, 2000, Pages 573-581

  Fuss, Martin ^a   Poljanc, Karin ^b   Hug, Eugen B ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

^c LOMA LINDA UNIVERSITY   (United States)

Author keywords

Brain; Children; Cognitive function; Full Scale IQ; Radiation therapy

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; BRAIN METASTASIS; BRAIN RADIATION; CHILD; CHILDHOOD CANCER; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; GLIOMA; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; RADIATION DOSE; REVIEW;

EID: 0033665252     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002327     Document Type: Review

References (45)

1. Fitting of normal tissue tolerance data to an analytic function
2. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer
3. Neurological and psychophysiological sequelae following different treatments of craniopharyngioma in children
4. Neurotoxicity in lymphoblastic leukaemia: Comparison of oral and intramuscular methotrexate and two doses of radiation
5. Neuropsychological sequelae of childhood cancer in long-term survivors
6. Cognitive effects of cranial irradiation in leukaemia: A survey and meta-analysis
7. Assessment of the long-term effects of primary radiation therapy for brain tumors in children
8. Late effects of treatment on the intelligence of children with posterior fossa tumors
9. Factors affecting intellectual outcome in pediatric brain tumor patients
10. Tolerance of normal tissue lo therapeutic irradiation
11. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma)
12. Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia
13. Medulloblastoma in childhood. Survival and functional results
14. Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia
15. Long-term psychological effects in children treated for intracranial tumors
16. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors
17. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia
18. Quality of life in children treated for brain tumors. Intellectual, emotional, and academic function
19. Assessment of quality of survival in children with medulloblastoma and cerebellar astrocytoma
20. Treatment of meningeal relapse in childhood acute lymphoblastic leukemia: II. A prospective study of intellectual loss specific to CNS relapse and therapy
21. Complication probability as assessed from dose-volume histograms
22. Endokrinologische funktions-storungen nach hirntumortherapie im kindesalter
23. Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation
24. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: Reduction of the supratentorial target volume
25. Cognitive function in children with leukemia. Effect of radiation dose and time since irradiation
26. The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia
27. Long-term survivors of leukemia treated in infancy: Factors associated with neuropsychologic status
28. Quality of survival among children treated for brain stem glioma
29. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose eraniospinal irradiation: A Pediatric Oncology Group study
30. Memory function in disease-free survivors of childhood acute lymphocytic leukemia given CNS prophylaxis with or without 1,800 cGy cranial irradiation
31. Neuropsychological status of children treated for brain tumors: A critical review and integrative analysis
32. A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation
33. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture
34. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: A prospective study
35. A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-Year results
36. Medulloblastoma in childhood: Comparative results of partial and total resection
37. Factors associated with IQ scores in long-term survivors of childhood acute lymphoblastic leukemia
38. Neuropsychological effects of cranial radiation: Current knowledge and future directions
39. Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia
40. Cognitive functioning in long-term survivors of childhood leukemia: A prospective analysis
41. Whole-brain irradiation and decline in intelligence: The influence of dose and age on IQ score
42. Late effects of radiotherapy on patients with cerebellar medulloblastoma
43. Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukaemia
44. The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia
45. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: Cranial radiation requires an accomplice